Panel Discussion : Can advanced analytics teach us to cure complex disease?
John P. Overington, Director of Bioinformatics at BenevolentAI will be joining a panel discussion around advanced analytics in drug discovery.
Chaired by Claus Bendtsen, Head of computational Biology at AstraZeneca, the panel will discuss the following topics:
Where can predictive modelling and network analysis have the most impact now and in the future?
How can machine learning resources be vetted and validated?
Discuss the pros and cons of representing complex dependencies using networks
Discuss the paths for the advancement of computational algorithms in developing methods for new medicines that are discovered and developed
Examples of exploring multiple hypotheses and within large sets of heterogenous data